These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 7692341

  • 21. Guinea pig striatum as a model of human dopamine deamination: the role of monoamine oxidase isozyme ratio, localization, and affinity for substrate in synaptic dopamine metabolism.
    Azzaro AJ, King J, Kotzuk J, Schoepp DD, Frost J, Schochet S.
    J Neurochem; 1985 Sep; 45(3):949-56. PubMed ID: 3928811
    [Abstract] [Full Text] [Related]

  • 22. Inhibition of monoamine oxidase-B by (-)-deprenyl potentiates neuronal responses to dopamine agonists but does not inhibit dopamine catabolism in the rat striatum.
    Paterson IA, Juorio AV, Berry MD, Zhu MY.
    J Pharmacol Exp Ther; 1991 Sep; 258(3):1019-26. PubMed ID: 1679846
    [Abstract] [Full Text] [Related]

  • 23. The presence of the type A form of monoamine oxidase within nigrostriatal dopamine-containing neurons.
    Demarest KT, Smith DJ, Azzaro AJ.
    J Pharmacol Exp Ther; 1980 Nov; 215(2):461-8. PubMed ID: 7441510
    [Abstract] [Full Text] [Related]

  • 24. Effects of selective monoamine oxidase (MAO) inhibitors on conditioned avoidance responses (CAR) of rats.
    Timár J, Knoll B, Gyarmati Z, Knoll J.
    Pol J Pharmacol Pharm; 1979 Nov; 31(4):251-60. PubMed ID: 523335
    [Abstract] [Full Text] [Related]

  • 25. Role of monoamine oxidase type A and B on the dopamine metabolism in discrete regions of the primate brain.
    Lakshmana MK, Rao BS, Dhingra NK, Ravikumar R, Govindaiah, Sudha S, Meti BL, Raju TR.
    Neurochem Res; 1998 Aug; 23(8):1031-7. PubMed ID: 9704592
    [Abstract] [Full Text] [Related]

  • 26. Alteration of dopamine synthesis in rat striatum subsequent to selective type A monoamine oxidase inhibition.
    Schoepp DD, Azzaro AJ.
    J Neurochem; 1981 Aug; 37(2):527-30. PubMed ID: 6790675
    [Abstract] [Full Text] [Related]

  • 27. Effects of monoamine oxidase inhibitors on levels of catechols and homovanillic acid in striatum and plasma.
    Hovevey-Sion D, Kopin IJ, Stull RW, Goldstein DS.
    Neuropharmacology; 1989 Aug; 28(8):791-7. PubMed ID: 2506486
    [Abstract] [Full Text] [Related]

  • 28. Deamination of norepinephrine, dopamine, and serotonin by type A monoamine oxidase in discrete regions of the rat brain and inhibition by RS-8359.
    Kumagae Y, Matsui Y, Iwata N.
    Jpn J Pharmacol; 1991 Jan; 55(1):121-8. PubMed ID: 1904113
    [Abstract] [Full Text] [Related]

  • 29. Lesion-induced reductions in trace amine accumulation: dependence on MAO inhibitor pretreatment.
    Nguyen TV, Juorio AV, Greenshaw AJ.
    Brain Res Bull; 1989 Feb; 22(2):197-200. PubMed ID: 2495844
    [Abstract] [Full Text] [Related]

  • 30. Modification of the striatal dopaminergic neuron system by carbon monoxide exposure in free-moving rats, as determined by in vivo brain microdialysis.
    Hara S, Mukai T, Kurosaki K, Kuriiwa F, Endo T.
    Arch Toxicol; 2002 Oct; 76(10):596-605. PubMed ID: 12373456
    [Abstract] [Full Text] [Related]

  • 31. In vivo labelling and axonal transport of monoamine oxidase in the rat basal ganglia using radioactive pargyline.
    Gramsbergen JB, Sebens JB, Korf J.
    J Neural Transm; 1986 Oct; 66(1):21-36. PubMed ID: 2426396
    [Abstract] [Full Text] [Related]

  • 32. Multiple, small dose administration of (-)deprenyl enhances catecholaminergic activity and diminishes serotoninergic activity in the brain and these effects are unrelated to MAO-B inhibition.
    Knoll J, Miklya I.
    Arch Int Pharmacodyn Ther; 1994 Oct; 328(1):1-15. PubMed ID: 7893186
    [Abstract] [Full Text] [Related]

  • 33. Effect of nonselective and selective inhibitors of monoamine oxidases A and B on pethidine toxicity in mice.
    Boden R, Botting R, Coulson P, Spanswick G.
    Br J Pharmacol; 1984 May; 82(1):151-4. PubMed ID: 6428496
    [Abstract] [Full Text] [Related]

  • 34. [History of deprenyl--the first selective inhibitor of monoamine oxidase type B].
    Knoll J.
    Vopr Med Khim; 1997 May; 43(6):482-93. PubMed ID: 9503565
    [Abstract] [Full Text] [Related]

  • 35. Plasma 5-hydroxyindoleacetic acid as an indicator of monoamine oxidase-A inhibition in rat brain and peripheral tissues.
    Celada P, Artigas F.
    J Neurochem; 1993 Dec; 61(6):2191-8. PubMed ID: 7504085
    [Abstract] [Full Text] [Related]

  • 36. Monoamine oxidase inhibitors increase preferentially extracellular 5-hydroxytryptamine in the midbrain raphe nuclei. A brain microdialysis study in the awake rat.
    Celada P, Artigas F.
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Jun; 347(6):583-90. PubMed ID: 7689703
    [Abstract] [Full Text] [Related]

  • 37. Monoamine oxidase inhibitors prevent striatal neuronal necrosis induced by transient forebrain ischemia.
    Matsui Y, Kumagae Y.
    Neurosci Lett; 1991 May 27; 126(2):175-8. PubMed ID: 1922929
    [Abstract] [Full Text] [Related]

  • 38. Inhibition of MAO-B protects against MDMA-induced neurotoxicity in the striatum.
    Sprague JE, Nichols DE.
    Psychopharmacology (Berl); 1995 Apr 27; 118(3):357-9. PubMed ID: 7542394
    [Abstract] [Full Text] [Related]

  • 39. Preferential deamination of dopamine by an A type monoamine oxidase in rat brain.
    Waldmeier PC, Delini-Stula A, Maître L.
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Apr 27; 292(1):9-14. PubMed ID: 934359
    [Abstract] [Full Text] [Related]

  • 40. The effect of selective type A or type B monoamine oxidase inhibition on the intrasynaptosomal deamination of (3H)serotonin in rat spinal cord tissue.
    Azzaro AJ, Amedro JB, Brown LM, Smith DJ, Williams GM.
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Jul 27; 338(1):9-13. PubMed ID: 2467212
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.